View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Methotrexate 8000 / Rituximab 375 / Temozolomide 150, CNS Lymphoma, cycle 2
Protocol-ID: 1860 V1.3 (Mini), MTRX8000/RITU375/TMZL150, CNS-NHL, C2Indication(s)
- NHL, CNS-NHL; ICD-10 C83.3
Links
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.06.2023